ReNu with MoistureLoc®

ReNu with MoistureLoc® Contact Lens Solution Litigation at The Lanier Law Firm

ReNu with Moisture Loc® cleanser was introduced to the market in late 2004 by Bausch & Lomb. This product was developed for soft contact lens wearers to condition their lenses to retain moisture while remaining clean for daily use. On April 13, 2006, Bausch & Lomb announced suspension of shipments of ReNu with Moisture Loc® due to reports of "fungal keratitis" infections in users of the solution.

Fungal keratitis is a serious eye infection that can develop through the whole depth of the cornea. Bausch & Lomb stated that February 18, 2006 was the earliest indication that there may be "an unusual occurrence with this infection" involving ReNu with Moisture Loc®. However, as reported by Reuters, Hong Kong authorities claim that they had noticed an increase in hospital admissions due to contact lens-related keratitis, and alerted Bausch & Lomb as early as November 2005.

On April 10, 2006, the CDC (Center for Disease Control) stated that it received reports of 109 cases of suspected fungal keratitis in 17 different states. Although the majority of patients have yet to be interviewed, the CDC confirmed that 28 of the 30, for whom complete information is available, wore soft contact lenses. The CDC also confirmed that 26 of those who used soft contact lenses reported using a Bausch & Lomb ReNu brand solution in the month prior to the onset of infection.

Both the CDC and the FDA continue to investigate reports of fungal keratitis in an effort to determine all contributing factors and/or products that place contact lens wearers at increased risk for infection.

If you or a loved one has used ReNu with Moisture Loc® and suffered any side effects, please contact our office for a free evaluation.

ReNu with Moisture Loc Information Links:

FDA Statement Regarding Voluntary Market Withdrawal of ReNu Moisture Loc

Preliminary Public Health Notification - Fungal Keratitis Infections Related to Contact Lens Use

FDA Advice to Patients

CDC Dispatch dated April 10, 2006

PDF
Print
bp-oil-spill-faq
Oil Spill Lawsuit

Law Firm News

Email Spam Patent Lawsuit Filed

The Lanier Law Firm filed a patent-infringement lawsuit against 36 companies including Apple and Google.


Lanier Named One of "The 25 Greatest Texas Lawyers"

Texas Lawyer selected W. Mark Lanier as one of the 25 greatest Texas lawyers of the past quarter-century.


BP Investigation - UPDATE

Many employees of BP may face huge retirement losses. Our team investigates.


Oil Spill Lawsuit - UPDATE

The Lanier Law Firm announced a class action lawsuit filed on behalf of people affected by the Gulf oil spill.


Decade's Most Influential Lawyers

Mark Lanier named one of "The Decade's Most Influential Lawyers" by editors of The National Law Journal.


Toyota Lawsuit

Mark Lanier discusses the Toyota lawsuit with Neil Cavuto on FOX News.


Pacemaker Lawsuit Successfully Resolved

The Lanier Law Firm settled a patent-infringement lawsuit against St. Jude Medical.


International Arbitration and Disputes

The Lanier Law Firm handles international arbitration and disputes for corporations.


Levaquin Side Effects
The antibiotic Levaquin is being targeted for causing irreparable injuries to patients.

Offices

Houston Law Office
713-659-5200 main
800-723-3216 toll free
713-659-2204 fax

New York Law Office
212-421-2800 main
800-723-3216 toll free
212-421-2878 fax

Los Angeles Law Office
800-723-3216 toll free
713-659-2204 fax

Palo Alto Law Office
650-322-9100 main
800-723-3216 toll free
650-322-9103 fax
Law Firm Locations: Houston Law Firm | New York Law Firm | Los Angeles Law Firm | Palo Alto Law Firm
© 2008 The Lanier Law Firm. All rights reserved. Disclaimer: Client's rights and responsibilities.
Past results do not guarantee similar outcomes in future cases.
Contact The Lanier Law Firm for more information.
Attorney Advertising